Table 4.
Therapeutic agents used after radiographic progression in LDA or remission.
| LDA (n = 105) | Remission (n = 57) | ||
|---|---|---|---|
| Therapeutic Agent | Number | Number | |
| Prednisone | 18 * | 2 * | |
| csDMARXDs/other drugs | Chloroquine | 10 * | - * |
| Cyclophosphamide | 1 | - | |
| Sulfasalazine | 11 * | 1 * | |
| Leflunomide | 14 | 8 | |
| Methotrexate | 13 | 11 | |
| Biologics | Abatacept | 8 | 2 |
| Ixekizumab | 1 | - | |
| Rituximab | 8 | 10 | |
| Tocilizumab | 6 | 10 | |
| TNF antagonists | Adalimumab | 9 | 4 |
| Etanercept | 7 | 3 | |
| Golimumab | 2 | 1 | |
| Infliximab | 10 | 2 | |
| Certolizumab | - | 2 | |
| tsDMARDs | Baricitinib | 2 | 1 |
| Tofacitinib | 3 | - | |
* Statistically significant differences p < 0.05.